Climb Bio (CLYM) Institutional Ownership $1.26 0.00 (0.00%) As of 07/8/2025 04:00 PM Eastern Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Climb Bio (NASDAQ:CLYM)CurrentInstitutional OwnershipPercentage69.76%Number ofInstitutional Buyers(last 12 months)13TotalInstitutional Inflows(last 12 months)$42.14MNumber ofInstitutional Sellers(last 12 months)0 Get CLYM Insider Trade Alerts Want to know when executives and insiders are buying or selling Climb Bio stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data CLYM Institutional Buying and Selling by Quarter Climb Bio Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails6/27/2025Goldman Sachs Group Inc.120,742$147K0.0%N/A0.179% 5/16/2025Goldman Sachs Group Inc.120,742$147K0.0%N/A0.179% 5/16/2025AQR Capital Management LLC21,808$27K0.0%N/A0.032% 5/16/2025Allostery Investments LP244,988$299K0.4%N/A0.363% 5/16/2025ADAR1 Capital Management LLC119,320$146K0.0%N/A0.177% 5/15/2025RA Capital Management L.P.31,419,267$38.33M0.6%N/A46.495% 5/14/2025Affinity Asset Advisors LLC1,500,000$1.83M0.2%N/A2.220% 5/13/2025Persistent Asset Partners Ltd145,760$178K0.1%N/A0.216% 5/12/2025Nuveen LLC39,034$48K0.0%N/A0.058% 5/9/2025Charles Schwab Investment Management Inc.70,093$86K0.0%N/A0.104% 5/8/2025XTX Topco Ltd27,660$34K0.0%N/A0.041% 5/7/2025TD Asset Management Inc89,400$109K0.0%N/A0.132% 4/30/2025Peapod Lane Capital LLC553,816$676K0.8%N/A0.821% 4/29/2025Bank of New York Mellon Corp64,914$79K0.0%N/A0.096% (Data available from 1/1/2016 forward) CLYM Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of CLYM shares? During the previous two years, 13 institutional investors and hedge funds held shares of Climb Bio. The most heavily invested institutionals were RA Capital Management L.P. ($38.33M), Affinity Asset Advisors LLC ($1.83M), Peapod Lane Capital LLC ($676K), Allostery Investments LP ($299K), Persistent Asset Partners Ltd ($178K), Goldman Sachs Group Inc. ($147K), and ADAR1 Capital Management LLC ($146K).Learn more on Climb Bio's institutional investors. What percentage of Climb Bio's stock is owned by institutional investors? 69.76% of Climb Bio's stock is owned by institutional investors. Learn more on CLYM's institutional investor holdings. Which institutional investors have been buying Climb Bio's stock? Of the 13 institutional investors that purchased Climb Bio's stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: RA Capital Management L.P. ($31.42M), Affinity Asset Advisors LLC ($1.50M), Peapod Lane Capital LLC ($553.82K), Allostery Investments LP ($244.99K), Goldman Sachs Group Inc. ($241.48K), Persistent Asset Partners Ltd ($145.76K), and ADAR1 Capital Management LLC ($119.32K). How much institutional buying is happening at Climb Bio? Institutional investors have bought a total of 34,537,544 shares in the last 24 months. This purchase volume represents approximately $42.14M in transactions. Related Companies Prothena Institutional Ownership Benitec Biopharma Institutional Ownership SNDL Institutional Ownership Heron Therapeutics Institutional Ownership Aura Biosciences Institutional Ownership Astria Therapeutics Institutional Ownership COMPASS Pathways Institutional Ownership Olema Pharmaceuticals Institutional Ownership Atea Pharmaceuticals Institutional Ownership Annexon Institutional Ownership This page (NASDAQ:CLYM) was last updated on 7/9/2025 by MarketBeat.com Staff From Our PartnersA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Climb Bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Climb Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
